Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer

Published:2016-08 Issue: Volume:98 Page:76-78
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Boyer Matthew J.,Gu Lin,Wang Xiaofei,Kelsey Chris R.,Yoo David S.,Onaitis Mark W.,Dunphy Frank R.,Crawford Jeffrey,Ready Neal E.,Salama Joseph K.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference8 articles.

1. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet,2009

2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

3. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study;Lynch;J. Clin. Oncol.,2012

4. Nivolumab versus docetaxel in advanced nonsquamous non-Small-Cell lung cancer;Borghaei;N. Engl. J. Med.,2015

5. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis;Frontiers in Immunology;2023-03-13

2. Imaging of the post-radiation chest in lung cancer;Clinical Radiology;2022-01

3. Mitochondrial creatine kinase 1 in non-small cell lung cancer progression and hypoxia adaptation;Respiratory Research;2021-07-01

4. Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review;Frontiers in Immunology;2021-03-30

5. Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer;Translational Lung Cancer Research;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3